Prognostication of the outcome of hepatocellular carcinoma: How to rely on science instead of on the art of Nostradamus

Digestive and Liver Disease

Volumn 41, Issue 6, 2009, Pages 382-384

  Trevisani, Franco ^a   Santi, Valentina ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; TREATMENT RESPONSE;

EID: 67349207863     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.03.001     Document Type: Note

References (10)

1. Iizuka N., Oka M., Yamada-Okabe H., Mori N., Tamesa T., Okada T., et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 62 (2002) 3939-3944
2. Hoshida Y., Villanueva A., Kobayashi M., Peix J., Chiang D.Y., Camargo A., et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359 19 (2008) 1995-2004
3. Primack A., Vogel C.L., Kyalwaazi S.K., Ziegler J.L., Simon R., and Anthony P.P. A staging system for hepatocellular carcinoma: prognostic factors in Ugandan patients. Cancer 35 (1975) 1357-1364
4. Okuda K., Ohtsuki T., Obata H., Tominatsu M., Okazaki N., Hasegawa H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56 4 (1985) 918-928
5. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998;28:751-5.
6. Sala M., Corner A., Varala M., and Bruix J. Prognostic prediction in patients with hepatocellular carcinoma. Sem Liver Dis 25 (2005) 171-180
7. Yen Y.H., Changchien C.S., Wang J.H., Kee K.M., Hung C.H., Hu T.H., et al. A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients. Dig Liv Dis 41 (2009) 431-441
8. Bruix J., Sherman M., and Practice Guidelines Committee. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42 5 (2005) 1208-1236
9. Llovet J.M., Di Bisceglie A.M., Bruix J., Kramer B.S., Lencioni R., Zhu A.X., et al. Panel of experts in HCC-design clinical trials. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100 (2008) 698-711
10. Cammà C., Di Marco V., Cabibbo G., Lattieri F., Sandonato L., Parisi P., et al. Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems. Pharmacol Ther Aliment 28 (2008) 62-75